European Commission logo
français français
CORDIS - Résultats de la recherche de l’UE
CORDIS

PROPOSAL FOR FUNDING RESEARCH DEVELOPMENT AND MANUFACTURING OF VACCINE AGAINST COVID-19

Description du projet

Financer le vaccin de la CEPI contre la COVID-19

Alors que la pandémie de COVID-19 met en péril des milliards de vies et fait payer un lourd tribut à l’économie mondiale, nombreux sont ceux qui s’empressent de développer des vaccins pour contrer la maladie. Avec des millions de morts dans le monde, tous les efforts focalisés sur le développement d’un vaccin s’avèrent cruciaux. À cette fin, le projet COVID-19 VACCINES, financé par l’UE, entend obtenir un cofinancement de la Commission européenne dans le but de soutenir les efforts de développement de vaccins par la Coalition pour les innovations en matière de préparation aux épidémies (CEPI). Celle-ci est à la recherche de programmes en matière de recherche et de développement de vaccins susceptibles de permettre au maximum de personnes d’accéder à des doses.

Objectif

Funding of research and innovation programmes for the development of novel SARS-CoV-2 vaccine against COVID-19 disease

The overall objective is to leverage co-funding from the European Commission to support CEPI’s COVID-19 vaccine programme development efforts. The COVID-19 outbreak has in a short timeframe grown to a global pandemic of historic proportions, with detrimental humanitarian and economic consequences. All evidence now suggests that eradication of COVID-19 is not feasible and that we face a global public health crisis which is unprecedented in modern times. Investing in vaccine development now is an investment in the future health for all in our societies and a return to social and economic development – both in Europe and in the rest of the globe.
CEPI is seeking to support scientifically excellent research and development vaccine development programmes of a nature that will allow the broadest global access of the vaccines that are ultimately developed both within the current pandemic crisis and beyond. This will help curb the current ongoing outbreak, that is resulting in human suffering and a grave global economic crisis. CEPI was set up to respond to the crisis, where our vision is a world in which epidemics are no longer a threat to humanity. Our strategic objectives are further aligned with the sustainable
development goals 3, 8 and 17. Of particular importance to CEPI’s work is to try and ensure that low- and low-middle income countries (LICs and LMICs, respectively) will have access to the vaccines to protect their most vulnerable population, as soon as a vaccine is made available and irrespective of their ability to pay. As the current pandemic has shown, viruses respect no borders. To successfully curb the COVID-19 pandemic and beyond, we must ensure that all countries have the necessary tools to control the outbreak domestically. No-one is safe until everyone is safe.

Appel à propositions

H2020-FPA-SGA-SC1-CEPI-2019

Voir d’autres projets de cet appel

Sous appel

H2020-SGA-SC1-CEPI-2020

Coordinateur

COALITION FOR EPIDEMIC PREPAREDNESS INNOVATIONS
Contribution nette de l'UE
€ 100 000 000,00
Adresse
SKOYEN ATRIUM ASKEKROKEN 11
0277 OSLO
Norvège

Voir sur la carte

Région
Norge Oslo og Viken Oslo
Type d’activité
Research Organisations
Liens
Coût total
€ 150 000 000,00